Neuroimaging Research Unit, Institute of Neurological Sciences, National Research Council, Germaneto (CZ), Italy.
Mov Disord. 2011 Apr;26(5):807-12. doi: 10.1002/mds.23660. Epub 2011 Mar 7.
Levodopa-induced dyskinesias represent disabling complications from long-term therapy with dopaminergic drugs for treating Parkinson's disease (PD). Although several neuroimaging studies have reported altered striatofrontal function that contributes to the emergence of these motor complications, the neuroanatomical correlates of this disorder are still unknown. Optimized voxel-based morphometry (VBM) was applied to the MRI brain images of 36 PD patients with levodopa-induced dyskinesias, 36 PD patients without levodopa-induced dyskinesias, and 32 age- and sex-matched controls. The VBM analysis comparing dyskinetic and nondyskinetic groups provided evidence of increased gray matter volume of the bilateral inferior frontal gyrus in dyskinetic patients, a finding that was more evident in patients with early-onset PD. No significant differences were detected in the dyskinetic and nondyskinetic groups when compared with the controls. Our findings suggest that the presence of dyskinesias in patients with PD is characterized by an aberrant neural plasticity that could play a role in the pathophysiology of these motor complications.
左旋多巴诱导的运动障碍是长期多巴胺能药物治疗帕金森病(PD)的一种致残性并发症。尽管有几项神经影像学研究报告了纹状体-额叶功能的改变,这些改变有助于这些运动并发症的出现,但这种疾病的神经解剖学相关性仍不清楚。我们应用优化的基于体素的形态测量学(VBM)对 36 名有左旋多巴诱导运动障碍的 PD 患者、36 名无左旋多巴诱导运动障碍的 PD 患者和 32 名年龄和性别匹配的对照者的 MRI 脑图像进行了分析。比较运动障碍组和非运动障碍组的 VBM 分析结果显示,运动障碍患者双侧额下回的灰质体积增加,这一发现在早发性 PD 患者中更为明显。与对照组相比,运动障碍组和非运动障碍组之间没有发现显著差异。我们的研究结果表明,PD 患者运动障碍的存在与异常的神经可塑性有关,这种可塑性可能在这些运动并发症的病理生理学中起作用。